Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Net Insight AB (publ)
Mandate

Vinge advises Net Insight AB (publ)

February 26, 2021 Intellectual Property M&A Capital Markets and Public M&A

Vinge advises Net Insight AB (publ) in connection with the signing of an agreement to divest its Resource Optimization business area, doing business as “ScheduALL“ to Xytech Systems Corp.

Closing of the transaction is subject to customary closing conditions.

The Vinge team advising Net Insight includes Kristina Ekberg, Ulrich Ziche, Stojan Arnerstål and Rikard Lindahl.

 (https://investors.netinsight.net/pressrelease/).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

 Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

 Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025